SCGB3A1 and cancer: OC-X treatments also caused surge upregulation of several important biomarkers within each cancer progression stage, including UCP1, NOSTRIN, SCGB3A1, ENG, EPAS1, SFTPD, and BMP4 (Figure 5A).